Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide.
Saved in:
| Title: | Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide. |
|---|---|
| Authors: | Freyer CW; Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Carulli A; Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Gier S; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA., Ganetsky A; Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Timlin C; Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Schuster M; Infectious Diseases Division, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Babushok D; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA., Frey NV; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA., Gill SI; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA., Hexner EO; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA., Luger SM; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA., Mangan JK; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA., Martin ME; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA., McCurdy SR; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA., Perl AE; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA., Porter DL; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA., Pratz K; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA., Smith J; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA., Stadtmauer EA; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA., Loren AW; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2022 Aug; Vol. 63 (8), pp. 1925-1933. Date of Electronic Publication: 2022 Feb 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35188052 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Freyer+CW%22">Freyer CW</searchLink>; Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Carulli+A%22">Carulli A</searchLink>; Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Gier+S%22">Gier S</searchLink>; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ganetsky+A%22">Ganetsky A</searchLink>; Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Timlin+C%22">Timlin C</searchLink>; Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Schuster+M%22">Schuster M</searchLink>; Infectious Diseases Division, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Babushok+D%22">Babushok D</searchLink>; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Frey+NV%22">Frey NV</searchLink>; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Gill+SI%22">Gill SI</searchLink>; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Hexner+EO%22">Hexner EO</searchLink>; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Luger+SM%22">Luger SM</searchLink>; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Mangan+JK%22">Mangan JK</searchLink>; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Martin+ME%22">Martin ME</searchLink>; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22McCurdy+SR%22">McCurdy SR</searchLink>; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Perl+AE%22">Perl AE</searchLink>; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Porter+DL%22">Porter DL</searchLink>; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Pratz+K%22">Pratz K</searchLink>; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Smith+J%22">Smith J</searchLink>; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Stadtmauer+EA%22">Stadtmauer EA</searchLink>; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Loren+AW%22">Loren AW</searchLink>; Blood and Marrow Transplantation Program, Hospital of the University of Pennsylvania, Abramson Cancer Center and the Division of Hematology and Oncology, Philadelphia, PA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2022 Aug; Vol. 63 (8), pp. 1925-1933. <i>Date of Electronic Publication: </i>2022 Feb 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35188052 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2022.2042686 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1925 Titles: – TitleFull: Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Freyer CW – PersonEntity: Name: NameFull: Carulli A – PersonEntity: Name: NameFull: Gier S – PersonEntity: Name: NameFull: Ganetsky A – PersonEntity: Name: NameFull: Timlin C – PersonEntity: Name: NameFull: Schuster M – PersonEntity: Name: NameFull: Babushok D – PersonEntity: Name: NameFull: Frey NV – PersonEntity: Name: NameFull: Gill SI – PersonEntity: Name: NameFull: Hexner EO – PersonEntity: Name: NameFull: Luger SM – PersonEntity: Name: NameFull: Mangan JK – PersonEntity: Name: NameFull: Martin ME – PersonEntity: Name: NameFull: McCurdy SR – PersonEntity: Name: NameFull: Perl AE – PersonEntity: Name: NameFull: Porter DL – PersonEntity: Name: NameFull: Pratz K – PersonEntity: Name: NameFull: Smith J – PersonEntity: Name: NameFull: Stadtmauer EA – PersonEntity: Name: NameFull: Loren AW IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2022 Aug Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1029-2403 Numbering: – Type: volume Value: 63 – Type: issue Value: 8 Titles: – TitleFull: Leukemia & lymphoma Type: main |
| ResultId | 1 |
